BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more
BioLife Solutions Inc (BLFS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.013x
Based on the latest financial reports, BioLife Solutions Inc (BLFS) has a cash flow conversion efficiency ratio of 0.013x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.92 Million) by net assets ($371.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioLife Solutions Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how BioLife Solutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioLife Solutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioLife Solutions Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ASA Gold and Precious Metals Ltd
NYSE:ASA
|
-0.072x |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
|
0.014x |
|
NCAB Group
ST:NCAB
|
0.199x |
|
Shanghai Tofflon Science Tech
SHE:300171
|
0.006x |
|
Shanghai SMI Holding Co Ltd
SHG:600649
|
0.036x |
|
Noah Holdings Ltd
NYSE:NOAH
|
0.000x |
|
Zhejiang Founder Motor Co Ltd
SHE:002196
|
0.025x |
|
Shanghai Runda Med Tech Co
SHG:603108
|
0.027x |
Annual Cash Flow Conversion Efficiency for BioLife Solutions Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of BioLife Solutions Inc from 1989 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $371.89 Million | $20.11 Million | 0.054x | +123.84% |
| 2024-12-31 | $348.91 Million | $8.43 Million | 0.024x | +165.28% |
| 2023-12-31 | $337.66 Million | $-12.50 Million | -0.037x | -58.79% |
| 2022-12-31 | $364.19 Million | $-8.49 Million | -0.023x | -129.61% |
| 2021-12-31 | $476.37 Million | $-4.84 Million | -0.010x | -131.98% |
| 2020-12-31 | $205.25 Million | $6.51 Million | 0.032x | +117.27% |
| 2019-12-31 | $83.03 Million | $1.21 Million | 0.015x | -73.15% |
| 2018-12-31 | $43.15 Million | $2.35 Million | 0.054x | -9.23% |
| 2017-12-31 | $10.09 Million | $605.00K | 0.060x | +104.39% |
| 2016-12-31 | $3.17 Million | $-4.33 Million | -1.367x | -170.91% |
| 2015-12-31 | $9.86 Million | $-4.97 Million | -0.504x | -122.32% |
| 2014-12-31 | $13.94 Million | $-3.16 Million | -0.227x | -1962.55% |
| 2013-12-31 | $-13.27 Million | $146.01K | -0.011x | +83.93% |
| 2012-12-31 | $-12.49 Million | $854.93K | -0.068x | -177.33% |
| 2011-12-31 | $-11.18 Million | $-989.92K | 0.089x | -32.50% |
| 2010-12-31 | $-9.55 Million | $-1.25 Million | 0.131x | -57.46% |
| 2009-12-31 | $-7.83 Million | $-2.41 Million | 0.308x | -24.55% |
| 2008-12-31 | $-5.17 Million | $-2.11 Million | 0.409x | -62.74% |
| 2007-12-31 | $-2.47 Million | $-2.71 Million | 1.097x | +127.74% |
| 2006-12-31 | $180.09K | $-712.20K | -3.955x | +73.60% |
| 2005-12-31 | $38.48K | $-576.33K | -14.977x | -1882.23% |
| 2004-12-31 | $612.96K | $515.10K | 0.840x | +233.41% |
| 2003-12-31 | $1.36 Million | $-854.23K | -0.630x | -113.04% |
| 2002-12-31 | $-554.25K | $-2.68 Million | 4.831x | +156.81% |
| 2001-12-31 | $310.77K | $-2.64 Million | -8.504x | -964.52% |
| 2000-12-31 | $3.63 Million | $-2.90 Million | -0.799x | -145.54% |
| 1999-12-31 | $818.40K | $-266.26K | -0.325x | -1699.60% |
| 1998-12-31 | $1.43 Million | $29.12K | 0.020x | +103.35% |
| 1997-12-31 | $2.46 Million | $-1.49 Million | -0.608x | -17.07% |
| 1996-12-31 | $3.99 Million | $-2.07 Million | -0.519x | -34.00% |
| 1995-12-31 | $3.98 Million | $-1.54 Million | -0.387x | 0.00% |
| 1994-12-31 | $3.98 Million | $-1.54 Million | -0.387x | +21.05% |
| 1993-12-31 | $5.30 Million | $-2.60 Million | -0.491x | +67.30% |
| 1992-12-31 | $5.60 Million | $-8.40 Million | -1.500x | -318.60% |
| 1991-12-31 | $12.00 Million | $-4.30 Million | -0.358x | +21.17% |
| 1990-12-31 | $5.50 Million | $-2.50 Million | -0.455x | -15.38% |
| 1989-12-31 | $3.30 Million | $-1.30 Million | -0.394x | -- |